Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hot flashes: aetiology and management.

D Barton1, C Loprinzi, D Wahner-Roedler

  • 1Mayo Clinic, Rochester, Minnesota 55905, USA.

Drugs & Aging
|October 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upper Limit on the Photoproduction Cross Section of the Spin-Exotic π_{1}(1600).

Physical review letters·2025
Same author

Saline and hydrocarbon-bearing fluids detected in shallow aquifers of southern New Brunswick, Canada: Natural occurrence, or deep migration along faults and industrial wellbores?

The Science of the total environment·2024
Same author

ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Strengthening Non-Communicable Disease Research Capacity in Thailand: Leveraging PhD Nurses and other Health Professionals.

Pacific Rim international journal of nursing research·2018
Same author

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Age Adjusted D-Dimer for exclusion of Pulmonary Embolism: a retrospective cohort study.

Irish medical journal·2018

Hormone therapy is the most effective treatment for hot flashes, reducing them by 80-90%. Newer antidepressants like venlafaxine offer a 60% reduction, providing key options for menopause symptom management.

Area of Science:

  • Reproductive Endocrinology
  • Menopause Management
  • Pharmacology

Background:

  • Hot flashes are a common menopause symptom impacting quality of life.
  • The precise pathophysiology of hot flashes remains unclear.
  • Numerous treatment strategies are available for managing hot flashes.

Purpose of the Study:

  • To provide evidence-based information on hot flash treatment options.
  • To compare the efficacy of hormonal and nonhormonal therapies.
  • To consider treatment for specific populations, like breast cancer survivors.

Main Methods:

  • Review of pharmacological and nonpharmacological interventions.
  • Analysis of treatment risks and benefits.
  • Evidence-based assessment of treatment effectiveness.

Related Experiment Videos

Main Results:

  • Hormone therapy (estrogen, progesterone, tibolone) is highly effective, reducing hot flashes by 80-90%.
  • Selective serotonin reuptake inhibitors (SSRIs), such as venlafaxine, are the most effective nonhormonal option, yielding ~60% reduction.
  • Treatment choice requires balancing risks and benefits for individual patients.

Conclusions:

  • Hormone therapy remains the gold standard for hot flash reduction.
  • Certain antidepressants offer significant relief for women seeking nonhormonal options.
  • Personalized treatment strategies are essential for effective hot flash management, especially in vulnerable groups.